Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 285

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Exosomal levels of miRNA-21 from cerebrospinal fluids associated with poor prognosis and tumor recurrence of glioma patients

Open access
Shi, Rui, Wang, Pei-Yin, Li, Xin-Yi, Chen, Jian-Xin, Li, Yan, Zhang, Xin-Zhong, Zhang, Chen-Guang, Jiang, Tao, Li, Wen-Bin, Ding, Wei, Cheng, Shu-Jun·2015·Oncotarget

Abstract

// Rui Shi 1 , Pei-Yin Wang 2 , Xin-Yi Li 4 , Jian-Xin Chen 1 , Yan Li 1 , Xin-Zhong Zhang 2 , Chen-Guang Zhang 3, 6 , Tao Jiang 5 , Wen-Bin Li 1, * , Wei Ding 3, 6 , Shu-Jun Cheng 1, * 1 Department of Oncology, Beijing Shijitan Hospital, Capital Medical University, Beijing, China 2 Department of Neurosurgery, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang Medical University, Henan, China 3 Beijing Key Laboratory for Tumor Invasion and Metastasis, Cancer Institute of Capital Medical University, Beijing, China 4 University of South Florida, Tampa, FL, USA 5 Department of Neurosurgery, Tiantan Hospital, Capital Medical University, Beijing, China 6 Department of Biochemistry, Molecular Biology Capital Medical University, Beijing, China * These authors have contributed equally to this work Correspondence to: Wen-Bin Li, e-mail: liwenbin@ccmu.edu.cn Shu-Jun Cheng, e-mail: chengshj@cae.cn Keywords: extracellular vesicles, cerebrospinal fluid, hsa-mir-21, glioma, cancer prognosis Received: March 04, 2015 Accepted: July 27, 2015 Published: August 10, 2015 ABSTRACT Glioma is a most common type of primary brain tumors. Extracellular vesicles, in the form of exosomes, are known to mediate cell–cell communication by transporting cell-derived proteins and nucleic acids, including various microRNAs (miRNAs). Here we examined the cerebrospinal fluid (CSF) from patients with recurrent glioma for the levels of cancer-related miRNAs, and evaluated the values for prognosis by comparing the measures of CSF-, serum-, and exosome-contained miR-21 levels. Samples from seventy glioma patients following surgery were compared with those from brain trauma patients as a non-tumor control group. Exosomal miR-21 levels in the CSF of glioma patients were found significantly higher than in the controls; whereas no difference was detected in serum-derived exosomal miR-21 expression. The CSF-derived exosomal miR-21 levels correlated with tumor spinal/ventricle metastasis and the recurrence with anatomical site preference. From additional 198 glioma tissue samples, we verified that miR-21 levels associated with tumor grade of diagnosis and negatively correlated with the median values of patient overall survival time. We further used a lentiviral inhibitor to suppress miR-21 expression in U251 cells. The results showed that the levels of miR-21 target genes of PTEN, RECK and PDCD4 were up-regulated at protein levels. Therefore, we concluded that the exosomal miR-21 levels could be demonstrated as a promising indicator for glioma diagnosis and prognosis, particularly with values to predict tumor recurrence or metastasis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.4699

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 285

Metadata

Authors
Shi, R., Wang, P.-Y., Li, X.-Y., Chen, J.-X., Li, Y., Zhang, X.-Z., Zhang, C.-G., Jiang, T., Li, W.-B., Ding, W., & Cheng, S.-J.
Venue
Oncotarget
Published
2015-08-10
Volume
6
Issue
29
Pages
26971-26981
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2107705644
Cited by
285
References
25
FWCI
7.98
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.